Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.
BRITISH JOURNAL OF CANCER, no. 6 (2008): 862-867
Advanced biliary tract carcinomas (BTCs) are often diagnosed at an advanced/metastatic stage and have a poor prognosis. The combination of gemcitabine and oxaliplatin (GEMOX) has shown promising activity in this setting. This international phase II study evaluated the efficacy and safety of GEMOX as first-line therapy in patients with adv...更多
下载 PDF 全文